paroxetine has been researched along with Cerebral Ischemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pretorius, E; Rajanikant, GK; Suvanish Kumar, VS | 1 |
| Harada, S; Matsuura, W; Tokuyama, S | 1 |
| Khasanov, NR; Khasanova, DR; Oslopov, VN; Safiullina, AA; Zhitkova, IuV | 1 |
3 other study(ies) available for paroxetine and Cerebral Ischemia
| Article | Year |
|---|---|
The Synergistic Combination of Everolimus and Paroxetine Exerts Post-ischemic Neuroprotection In Vitro.
Topics: Brain Ischemia; Cell Hypoxia; Cells, Cultured; Drug Synergism; Everolimus; Humans; Neurons; Neuroprotection; Neuroprotective Agents; Oxygen; Paroxetine | 2018 |
Effects of Adjuvant Analgesics on Cerebral Ischemia-Induced Mechanical Allodynia.
Topics: Amines; Analgesics; Animals; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Antidepressive Agents, Tricyclic; Brain Ischemia; Carbamazepine; Chemotherapy, Adjuvant; Cyclohexanecarboxylic Acids; Cyclopropanes; Gabapentin; gamma-Aminobutyric Acid; Hyperalgesia; Imipramine; Indomethacin; Male; Mexiletine; Mice; Milnacipran; Morphine; Neuralgia; Paroxetine; Selective Serotonin Reuptake Inhibitors | 2016 |
[Efficacy of adepress (paroxetine) in the treatment of depression in patients with chronic cerebral ischemia in the late recovery phase of ischemic stroke with the estimation of the velocity of passive transmembrane ion transport].
Topics: Aged; Antidepressive Agents, Second-Generation; Brain Ischemia; Chronic Disease; Cognition; Depression; Erythrocyte Membrane; Female; Humans; Ion Transport; Lithium; Male; Middle Aged; Paroxetine; Sodium; Treatment Outcome | 2012 |